IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Gottlieb talks CBD regulation, lab meat, allergen labeling at House Appropriations hearing

FDA’s regulatory plans for CBD-infused products, cell-cultured meats, sesame allergen labeling and imported foods were hot issues when FDA Commissioner Scott Gottlieb testified at House hearing on Wednesday (Feb. 27).


Related Content

USDA, FDA would report plan to regulate cell-based meat plan this spring under spending bill
DeLauro blasts FDA for delaying FSMA ag water standards in wake of lettuce report
FDA probe suggests poor ag water sanitation may have played a role in latest romaine outbreak
Gottlieb signals FDA looking for ‘pathways’ for CBD products
FDA eyes adding sesame to allergen labels, but experts say legal path unclear


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts